Ana Cristina Roginski

Ana Cristina Roginski

Auto-generated profile, based on publicly available information

Ana Cristina Roginski

Biodesign Center for Health Through Microbiomes, Arizona State University, Tempe, AZ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
ARAna Cristina Roginski
Ana Cristina Roginski
AWAlessandro Wajner
Alessandro Wajner
CCCristiane Cecatto
Cristiane Cecatto
SWSimone Magagnin Wajner
Simone Magagnin Wajner
RCRoger Frigério Castilho
Roger Frigério Castilho
Alexandre Umpierrez AmaralAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral

1 February 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
CCCristiane Cecatto
Cristiane Cecatto
AAAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral
ARAna Cristina Roginski
Ana Cristina Roginski
RCRoger Frigério Castilho
Roger Frigério Castilho
MWMoacir Wajner
Moacir Wajner

29 April 2019 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ARAna Cristina Roginski
Ana Cristina Roginski
CCCristiane Cecatto
Cristiane Cecatto
SWSimone Magagnin Wajner
Simone Magagnin Wajner
FCFernanda Dal’mAso Camera
Fernanda Dal’mAso Camera
RCRoger Frigério Castilho
Roger Frigério Castilho
Alexandre Umpierrez AmaralAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral

27 March 2023 in Cells
Verified
Journal Article
Open access
PDF file
RMRafael Aguiar Marschner
Rafael Aguiar Marschner
ARAna Cristina Roginski
Ana Cristina Roginski
Rafael Teixeira RibeiroRafael Teixeira Ribeiro
Rafael Teixeira Ribeiro
LLLarisse Longo
Larisse Longo
MAMario Reis Alvares-da-Silva
Mario Reis Alvares-da-Silva
SWSimone Magagnin Wajner
Simone Magagnin Wajner
Metabolic dysfunction-associated fatty liver disease (MAFLD) has gained worldwide attention as a public health problem. Nonetheless, lack of enough mechanistic knowledge restrains effective treatments. It is known that thyroid hormone triiodothyronine (T3) regulates hepatic lipid metabolism, and mitochondrial function. Liver dysfunction of type 3 deiodinase (D3) contributes to MAFLD, but its role is not fully understood. Objective: To evaluate the role of D3 in the progression of MAFLD in an animal model. Methodology: Male/adult Sprague Dawley rats (n = 20) were allocated to a control group (2.93 kcal/g) and high-fat diet group (4.3 kcal/g). Euthanasia took place on the 28th week. D3 activity and expression, Uncoupling Protein 2 (UCP2) and type 1 deiodinase (D1) expression, oxidative stress status, mitochondrial, Krebs cycle and endoplasmic reticulum homeostasis in liver tissue were measured. Results: We observed an increase in D3 activity/expression (p < 0.001) related to increased thiobarbituric acid reactive substances (TBARS) and carbonyls and diminished reduced glutathione (GSH) in the MAFLD group (p < 0.05). There was a D3-dependent decrease in UCP2 expression (p = 0.01), mitochondrial capacity, respiratory activity with increased endoplasmic reticulum stress in the MAFLD group (p < 0.001). Surprisingly, in an environment with lower T3 levels due to high D3 activity, we observed an augmented alpha-ketoglutarate dehydrogenase (KGDH) and glutamate dehydrogenase (GDH) enzymes activity (p < 0.05). Conclusion: Induced D3, triggered by changes in the REDOX state, decreases T3 availability and hepatic mitochondrial capacity. The Krebs cycle enzymes were altered as well as endoplasmic reticulum stress. Taken together, these results shed new light on the role of D3 metabolism in MAFLD.

4 August 2021 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
BSBianca Seminotti
Bianca Seminotti
ARAna Cristina Roginski
Ana Cristina Roginski
ÂZÂngela Zanatta
Ângela Zanatta
Alexandre Umpierrez AmaralAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral
TFThabata Fernandes
Thabata Fernandes
MWMoacir Wajner
Moacir Wajner

12 April 2025 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
CPCamila Vieira Pinheiro
Camila Vieira Pinheiro
Rafael Teixeira RibeiroRafael Teixeira Ribeiro
Rafael Teixeira Ribeiro
ARAna Cristina Roginski
Ana Cristina Roginski
MBMorgana Brondani
Morgana Brondani
ÂZÂngela Beatris Zemniaçak
Ângela Beatris Zemniaçak
GLGuilhian Leipnitz
Guilhian Leipnitz